Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes

Area of Science:

• Biochemistry
• Physiology
• Molecular Biology

Background:

• Calpain activity is regulated by calpastatin, a specific inhibitor.
• An imbalance in the calpain:calpastatin ratio is implicated in various cellular dysfunctions.
• Erythrocyte plasma membrane (Ca+Mg)ATPase plays a crucial role in calcium homeostasis.

Purpose of the Study:

• To investigate the effect of reduced calpastatin levels on erythrocyte (Ca+Mg)ATPase activity.
• To determine the role of calpain in the degradation of (Ca+Mg)ATPase in specific rat strains.

Main Methods:

• Enzyme activity assays of (Ca+Mg)ATPase in erythrocytes.
• Comparison between Milan hypertensive rat strain (MHS), Milan low calpastatin rat strain (MLCS), and Milan normotensive rat strain (MNS).
• Analysis of protein fragments using gel electrophoresis.

Main Results:

• Erythrocytes from MHS and MLCS rats exhibited significantly lower (Ca+Mg)ATPase activity compared to MNS rats.
• A five-fold reduction in calpastatin activity was observed in MHS and MLCS rats.
• The presence of 124 kDa fragments of (Ca+Mg)ATPase was detected, indicating proteolytic cleavage by calpain.

Conclusions:

• A reduced calpastatin level leads to increased calpain activity, consequently decreasing erythrocyte (Ca+Mg)ATPase activity.
• Calpain proteolytically degrades the 136 kDa (Ca+Mg)ATPase into 124 kDa fragments in MHS and MLCS rats.
• This proteolytic imbalance contributes to erythrocyte dysfunction in hypertensive and low calpastatin rat models.